How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates predispositions in key metabolic pathwaysincluding GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 variantsthat may influence how individual patients respond to GLP-1 therapy and weight regulation
GIP activation enhances the effects of GLP-1, resulting in greater satiety, improved blood sugar control, and more significant fat reduction than GLP-1-only medications
They: Reduce appetite and slow gastric emptying Help people feel full on much smaller portions Drive impressive average fat loss in clinical trials The catch: when your appetite is that suppressed, its easy to hit protein but under-shoot micronutrientsespecially if your food choices become repetitive or ultra-simple
The clinic is cash-pay only, with no in-network billing and no brand-name coverage workaround
Berlin, Heidelberg, New York, Springer Verlag, pp 11-27